{
  "author": "paisleyno2",
  "the_new_excerpt": "Will trade on the Canadian NEO Exchange under the ticker PSYK. The ETF includes\ncompanies in the Canadian legal psychedelics industry, as well as U.S. companies\nengaged in legal activities involving psychedelic drugs and substances. The\npurpose of the ETF is to \"invest in, and indirectly derive…",
  "original_created_utc": 1611310369,
  "localize": [
    {
      "locale": "zh",
      "the_new_excerpt": "将在加拿大NEO交易所交易，股票代码为PSYK。该ETF包括\n加拿大合法迷幻药行业的公司，以及美国的公司。\n从事涉及迷幻药物和物质的合法活动； 该\nETF的目的是 \"投资于，并间接获得...",
      "title": "地平线的迷幻ETF（PSYK）预计将于2021年1月26日开始交易，并将17家迷幻公司纳入史上首只迷幻ETF中"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "將在加拿大NEO交易所交易，股票代碼爲PSYK。該ETF包括\n加拿大合法迷幻藥行業的公司，以及美國的公司。\n從事涉及迷幻藥物和物質的合法活動； 該\nETF的目的是 \"投資於，並間接獲得...",
      "title": "地平線的迷幻ETF（PSYK）預計將於2021年1月26日開始交易，並將17家迷幻公司納入史上首隻迷幻ETF中"
    }
  ],
  "title": "Horizon's Psychedelic ETF (PSYK) is expected to commence trading Jan. 26, 2021 and includes 17 psychedelic companies in the first ever Psychedelic ETF",
  "created_utc": 1611344034,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Will trade on the Canadian NEO Exchange under the ticker PSYK. The ETF includes companies in the Canadian legal psychedelics industry, as well as U.S. companies engaged in legal activities involving psychedelic drugs and substances. The purpose of the ETF is to &quot;invest in, and indirectly derive revenues from, companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances.&quot;</p>\n\n<p>MER = 0.85% </p>\n\n<p>The ETF will include: </p>\n\n<ul>\n<li>Johnson &amp; Johnson (JNJ)</li>\n<li>AbbVie Inc (ABBV)</li>\n<li>COMPASS Pathways (CMPS)</li>\n<li>Field Trip Health (FTRP)</li>\n<li>MindMed (MMED)</li>\n<li>Greenbrook TMS Inc (GTMS)</li>\n<li>Entheon Biomedical (ENBI)</li>\n<li>Seelos Therapeutics (SEEL)</li>\n<li>Cybin (CYBN)</li>\n<li>Mind Cure Health (MCUR)</li>\n<li>Havn Life Sciences (HAVN)</li>\n<li>Numinus (NUMI)</li>\n<li>Mydecine Innovations (MYCO)</li>\n<li>Nova Mentis (NOVA)</li>\n<li>Psyched Wellness (PSYC)</li>\n<li>Revive Therapeutics (RVV)</li>\n<li>Red Light Holland (TRIP)</li>\n</ul>\n\n<p>In this case, the underlying index is the North American Psychedelic Stock Index, provided by German-based index provider Solactive.</p>\n\n<p><strong>It&#39;s interesting to note that $NUMI (Numinus Wellness Inc) has 3x the share allocation vs. $MMED (MINDMED INC) within the index.</strong></p>\n\n<p><strong>My Take:</strong></p>\n\n<p>The weightings of the Solactive index is interesting. Within the index, $NUMI (Numinus Wellness Inc) has 3x the share allocation vs. $MMED (MINDMED INC). $NUMI being the Canadian leader in the psychedelic space. $MMED being the lead player in the market with a $1.50B Market Cap vs. $NUMI at $250M. At 6x the market cap, I expect significant upside potential for $NUMI with the launch of the ETF. </p>\n\n<p>Overall I am very bullish on this ETF. The index is up 12.70% since Monday. </p>\n\n<p><a href=\"https://www.solactive.com/indices/?se=1&amp;index=DE000SL0B7H2\">https://www.solactive.com/indices/?se=1&amp;index=DE000SL0B7H2</a></p>\n\n<p>For Americans, while the original listing is set to be in CAD, Horizons may also list on a U.S. exchange under the ticker symbol PSYK.U.</p>\n\n<p>Numinus Wellness Inc trades OTC under $LKYSF and under $NUMI on the TSX Venture.</p>\n</div><!-- SC_ON -->",
  "score": 71,
  "permalink": "/r/investing/comments/l2kt85/horizons_psychedelic_etf_psyk_is_expected_to/",
  "subreddit": "investing",
  "id": "l2kt85",
  "is_self": true,
  "media": null,
  "is_video": false
}